Study Investigating ASP3082 in Patients With Metastatic/Locally Advanced Non-small-cell Lung Cancer (NSCLC) and Pancreatic Ductal Adenocarcinoma (PDAC), With Biomarker Analysis to Characterize Response/Resistance

Abroad (travel likely)RecruitingPHASE2

Conditions

Metastatic/Locally Advanced Non-Small-Cell Lung Cancer · Metastatic/Locally Pancreatic Ductal Adenocarcinoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Gustave Roussy, Villejuif, France, France
Contact: Study coordinator (Yohann Loriot, MD, PhD) · Yohann.LORIOT@gustaveroussy.fr · +33 (0)1 42 11 42 11
Contact: Study coordinator (Fernanda Mosele, MD) · mariafernanda.mosele@gustaveroussy.fr
Institut Bergonié, Bordeaux, France
Contact: Study coordinator (Véronique DEBIEN) · v.debien@bordeaux.unicancer.fr · +33 (0)5 56 33 33 33
Centre Georges François Leclerc, Dijon, France
Contact: Study coordinator (François GHIRINGHELLI) · dghiringhelli@cgfl.fr · +33 (0)3 80 73 75 06
Institut Paoli Calmettes, Marseille, France
Contact: Study coordinator (Brice CHANEZ) · chanezb@ipc.unicancer.fr · +33 (0)4 91 22 37 61
Institut de Cancérologie de l'Ouest, Saint-Herblain, France
Contact: Study coordinator (Sandrine HIRET) · sandrine.hiret@ico.unicancer.fr · +33 (0)2 40 67 99 00
Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France
Contact: Study coordinator (Aurélien LAMBERT) · a.lambert@nancy.unicancer.fr · +33 (0)3 83 59 85 64

View source on ClinicalTrials.gov Contact study team (email)